Literature DB >> 15021879

The STAT3 isoforms alpha and beta have unique and specific functions.

Diego Maritano1, Michelle L Sugrue, Silvia Tininini, Sarah Dewilde, Birgit Strobl, XinPing Fu, Victoria Murray-Tait, Roberto Chiarle, Valeria Poli.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is the main mediator of interleukin 6 (IL-6)-type cytokine signaling. It exists in two isoforms: the full-length STAT3 alpha and the truncated STAT3 beta, generally thought to act as a dominant negative factor. To assess their relative functions, we ablated the expression of either isoform by gene targeting. We show here that in vivo STAT3 beta is not a dominant negative factor. Its expression can rescue the embryonic lethality of a STAT3-null mutation and it can by itself induce the expression of specific STAT3 target genes. Nevertheless, STAT3 alpha has nonredundant roles such as modulation of cellular responses to IL-6 and mediation of IL-10 function in macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021879     DOI: 10.1038/ni1052

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  85 in total

1.  Antitumorigenic potential of STAT3 alternative splicing modulation.

Authors:  Francesca Zammarchi; Elisa de Stanchina; Eirini Bournazou; Teerawit Supakorndej; Kathryn Martires; Elyn Riedel; Adriana D Corben; Jacqueline F Bromberg; Luca Cartegni
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 2.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

3.  Genome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3.

Authors:  Francesco Vallania; Davide Schiavone; Sarah Dewilde; Emanuela Pupo; Serge Garbay; Raffaele Calogero; Marco Pontoglio; Paolo Provero; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

4.  Macrophages Promote Aortic Valve Cell Calcification and Alter STAT3 Splicing.

Authors:  Michael A Raddatz; Tessa Huffstater; Matthew R Bersi; Bradley I Reinfeld; Matthew Z Madden; Sabrina E Booton; W Kimryn Rathmell; Jeffrey C Rathmell; Brian R Lindman; Meena S Madhur; W David Merryman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-16       Impact factor: 8.311

5.  Cr(VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck.

Authors:  Kimberley A O'Hara; Rasilaben J Vaghjiani; Antonia A Nemec; Linda R Klei; Aaron Barchowsky
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

6.  Prevention of trauma and hemorrhagic shock-mediated liver apoptosis by activation of stat3alpha.

Authors:  Ana Moran; Ayse Akcan Arikan; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Valeria Poli; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2008-06-15

7.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03

Review 8.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

Review 9.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

10.  Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jihyun Lee; William M Baldwin; Chih-Yuan Lee; Stephen Desiderio
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.